HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Pradat Selected Research

P Pradat Research Topics

Disease

8Infections
03/2019 - 03/2000
4Chronic Hepatitis C
01/2014 - 05/2000
4Fibrosis (Cirrhosis)
09/2013 - 08/2007
2Virus Diseases (Viral Diseases)
09/2013 - 08/2007
2Chronic Hepatitis B
04/2013 - 09/2000
2Hepatitis B
04/2013 - 01/2009
2Hepatitis C
08/2007 - 07/2003
1Critical Illness (Critically Ill)
03/2023
1Hepatopulmonary Syndrome
01/2020
1Dysbiosis
03/2019
1Glaucoma
12/2018
1Choroid Diseases
12/2018
1End Stage Liver Disease
01/2014
1Liver Diseases (Liver Disease)
08/2007
1Hepatocellular Carcinoma (Hepatoma)
08/2007
1Coinfection
08/2007

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
09/2013 - 08/2007
2Antiviral Agents (Antivirals)IBA
11/2018 - 08/2007
2AntigensIBA
08/2007 - 07/2003
1Fluconazole (Zonal)FDA LinkGeneric
03/2023
1VancomycinFDA LinkGeneric
03/2019
1LactamsIBA
03/2019
1Retinaldehyde (Retinal)IBA
12/2018
1telaprevirIBA
01/2014
1W 12IBA
01/2014
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2014
1DNA VaccinesIBA
04/2013
1Liver ExtractsIBA
04/2013
1CytokinesIBA
04/2013
1Proteins (Proteins, Gene)FDA Link
04/2013
1Transaminases (Aminotransferases)IBA
01/2009
1Alanine Transaminase (SGPT)IBA
10/2008
1TransferasesIBA
10/2008
1Biomarkers (Surrogate Marker)IBA
10/2008
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
10/2008
1RNA (Ribonucleic Acid)IBA
08/2007
1HLA-DRB1 Chains (HLA DRB1)IBA
08/2007
1Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2007
1peginterferon alfa-2b (Pegintron)FDA Link
02/2007
1Ribavirin (Virazole)FDA LinkGeneric
02/2007
1AntibodiesIBA
04/2004
1Viral RNAIBA
04/2004
1Hepatitis B e AntigensIBA
09/2000
1InterferonsIBA
05/2000

Therapy/Procedure

8Therapeutics
03/2019 - 05/2000
3Liver Transplantation
01/2020 - 08/2007
1Immunotherapy
04/2013
1Retreatment
02/2007
1Tattooing
03/2000